Retrospective study of dasatinib in recurrent high-grade glioma (HGG) patients who failed bevacizumab.

被引：1
|
作者：
Lu-Emerson, C. [1 ]
Norden, A. D. [1 ]
Drappatz, J. [1 ]
Quant, E. C. [1 ]
Ciampa, A. S. [1 ]
Doherty, L. M. [1 ]
LaFrankie, D. C. [1 ]
Wen, P. Y. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e12525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12525
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETROSPECTIVE STUDY OF DASATINIB IN RECURRENT HIGH-GRADE GLIOMA (HGG) PATIENTS WHO FAILED BEVACIZUMAB
    Lu-Emerson, Christine
    Norden, Andrew D.
    Drappatz, Jan
    Quant, Eudocia C.
    Ciampa, Abigail S.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Wen, Patrick Y.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 38 - 38
  • [2] OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) TREATED WITH BEVACIZUMAB
    Ye, L.
    Hasani, A.
    Nowak, A.
    King, A.
    Long, A.
    Trevenen, M.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 72 - 72
  • [3] Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG).
    Grisanti, S.
    Pedersini, R.
    Ferrari, V. D.
    Liserre, R.
    Consoli, F.
    Poliani, L.
    Boglione, M.
    Rangoni, G.
    Montini, E.
    Simoncini, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).
    Drappatz, J.
    Raizer, J. J.
    Schiff, D.
    Chi, A. S.
    Batchelor, T.
    Snodgrass, S. M.
    Quant, E. C.
    Norden, A. D.
    Beroukhim, R.
    Grimm, S. A.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Gerard, M.
    Hammond, S.
    Wen, P. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Beatrice Detti
    Silvia Scoccianti
    Maria Ausilia Teriaca
    Virginia Maragna
    Victoria Lorenzetti
    Sara Lucidi
    Chiara Bellini
    Daniela Greto
    Isacco Desideri
    Lorenzo Livi
    [J]. La radiologia medica, 2021, 126 : 1249 - 1254
  • [6] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Detti, Beatrice
    Scoccianti, Silvia
    Teriaca, Maria Ausilia
    Maragna, Virginia
    Lorenzetti, Victoria
    Lucidi, Sara
    Bellini, Chiara
    Greto, Daniela
    Desideri, Isacco
    Livi, Lorenzo
    [J]. RADIOLOGIA MEDICA, 2021, 126 (09): : 1249 - 1254
  • [7] BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA (HGG): ANALYSIS OF MONOTHERAPY VERSUS COMBINATION WITH CHEMOTHERAPY FROM A CANADIAN RETROSPECTIVE CHART REVIEW
    Kavan, Petr
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie-Christine
    Muanza, Thierry
    Del Maestro, Rolando
    Petrecca, Kevin
    Sharma, Rajesh
    [J]. NEURO-ONCOLOGY, 2012, 14 : 76 - 76
  • [8] BEVACIZUMAB AND CARBOPLATIN FOR RECURRENT HIGH-GRADE GLIOMA
    Mrugala, Maciej M.
    Lee, Laurie K.
    Graham, Carrie A.
    Fink, James R.
    Spence, Alexander M.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 55 - 55
  • [9] RE-IRRADIATION WITH AND WITHOUT BEVACIZUMAB IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMAS (HGG): RETROSPECTIVE ANALYSIS OF 13 PATIENTS
    Hundsberger, T.
    Bruegge, D.
    Weder, P.
    Weber, J.
    Plasswilm, L.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 88 - 88
  • [10] Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study
    Fat, Mary Jane Lim
    Maurice, Catherine
    Maganti, Manjula
    Mason, Warren P.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (01) : 56 - 61
12345